Arcturus Therapeutics Holdings
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-8.769.883.220.98
Price/Sales ratio
2.001.180.750.40
Earnings per Share (EPS)
$-1.98$1.76$5.40$17.65

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-1.55-6.98-2.35-2.26-2.09-5.10-12.34-4.7047.97-28.24-11.25-5.10
Price/Sales ratio
N/A22.132.831.892.896.3192.3378.802.175.322.992.89
Price/Book Value ratio
2.551.951.220.723.345.082.224.261.653.012.635.08
Price/Cash Flow ratio
-1.80-7.48-3.00-53.61-2.19-20.35-20.55-7.2114.01-46.38-13.24-20.35
Price/Free Cash Flow ratio
-1.79-7.41-2.99-34.69-2.05-18.06-19.74-7.0318.48-39.98-11.26-18.06
Price/Earnings Growth ratio
-0.010.113.690.050.053.67-0.19-0.03-0.450.060.730.05
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/A99.16%98.55%96.84%-7.80%-56.04%-486.49%-1290.56%30.47%98.12%5.60%-7.80%
Operating Profit Margin
N/A-320.91%-123.47%-80.72%-138.45%-122.72%-749.80%-1641.33%5.91%-49.57%-25.29%-138.45%
Pretax Profit Margin
N/A-316.03%-120.35%-83.86%-138.29%-125.02%-756.34%-1647.98%5.17%-17.68%-26.05%-138.29%
Net Profit Margin
N/A-316.86%-120.70%-83.87%-138.29%-123.72%-748.12%-1673.78%4.54%-18.84%-26.59%-138.29%
Effective Tax Rate
0.05%-0.26%-0.29%-0.00%-0.97%1.03%1.08%-1.56%12.16%-6.57%-2.08%1.03%
Return on Assets
-147.11%-27.13%-47.70%-20.95%-49.28%-31.31%-14.97%-52.66%2.07%-6.92%-14.07%-49.28%
Return On Equity
-164.63%-28.05%-52.09%-32.26%-159.69%-99.72%-17.99%-90.64%3.45%-10.67%-32.86%-159.69%
Return on Capital Employed
-165.86%-28.41%-53.28%-25.60%-68.97%-41.94%-16.75%-69.16%3.76%-22.51%-18.64%-68.97%
Liquidity Ratios
Current Ratio
9.3122.2511.824.603.323.489.44N/AN/AN/A3.173.48
Quick Ratio
9.3122.3011.944.473.323.489.443.803.174.713.103.48
Cash ratio
0.917.080.532.262.913.349.343.723.083.563.082.91
Days of Sales Outstanding
N/A19.5065.0513.47103.8238.2581.3199.434.9074.194.2338.25
Days of Inventory outstanding
N/A-830.19-646.811.29K0.00N/AN/A0.00N/AN/AN/AN/A
Operating Cycle
N/A-810.69-581.761.31K103.8238.2581.3199.434.9074.19N/A38.25
Days of Payables Outstanding
N/A407.944.16K1.59K51.5465.1870.2921.3619.00651.61N/A65.18
Cash Conversion Cycle
N/A-1.21K-4.74K-280.3052.28-26.9211.0178.07-14.10-577.42N/A-26.92
Debt Ratios
Debt Ratio
N/AN/A0.00N/A0.220.180.030.160.13N/A0.390.22
Debt Equity Ratio
N/AN/A0.00N/A0.720.580.030.270.22N/A0.660.66
Long-term Debt to Capitalization
N/AN/AN/AN/A0.420.360.030.15N/AN/A0.100.36
Total Debt to Capitalization
N/AN/A0.00N/A0.420.360.030.210.18N/A0.250.36
Interest Coverage Ratio
-16.53K-635.41-177.23-69.94-117.26-29.87-86.06N/AN/AN/A-41.69-117.26
Cash Flow to Debt Ratio
N/AN/A-144.66N/A-2.09-0.42-2.83-2.130.52N/A-0.59-2.09
Company Equity Multiplier
1.111.031.091.533.233.181.201.721.661.541.663.18
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/A-2.95-0.94-0.03-1.31-0.31-4.49-10.920.15-0.11-0.22-1.31
Free Cash Flow / Operating Cash Flow Ratio
1.001.001.001.541.071.121.041.020.751.161.171.07
Cash Flow Coverage Ratio
N/AN/A-144.66N/A-2.09-0.42-2.83-2.130.52N/A-0.59-2.09
Short Term Coverage Ratio
N/AN/A-144.66N/AN/AN/A-34.28-6.000.52N/A-0.88N/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A